Salarius Pharmaceuticals cuts half of workforce despite positive clinical developments

Despite positive feedback from the FDA, Salarius Pharmaceuticals cut half of its workforce in early August. The company also is exploring strategic alternatives, including the possibility of a merger, acquisition or more.